Clinical trial
Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder
NCT05844059 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lower Urinary Tract Symptoms After Intravesical Therapy With Mitomycin C or BCG in Patients With Carcinoma of the Bladder
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 21, 2023
- Completion date
- April 24, 2026
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chemotherapeutic toxicity, chemotherapy effect, lower urinary tract symptoms, overactive bladder